Home / Health / WHO Launches Life-Saving Ebola Drug Trial
WHO Launches Life-Saving Ebola Drug Trial
3 Jul
Summary
- First patient enrolled in a new Ebola treatment trial in the DRC.
- Over 1,400 cases and 438 deaths confirmed in the ongoing outbreak.
- Trial is a collaboration involving UK, Belgian, and DRC research institutes.
A crucial clinical trial for potential treatments against the strain of virus causing the current deadly Ebola outbreak has begun in the Democratic Republic of Congo (DRC). The World Health Organization (WHO) announced that the first patient has been enrolled in the trial, marking a significant step in combating the disease.
As of the announcement, the outbreak had resulted in over 1,400 confirmed cases and 438 deaths within the DRC. The Bundibugyo virus strain is highly infectious, and currently, there are no approved vaccines or treatments. This trial, sponsored by the WHO, involves coordinated efforts from scientists at key research institutions.
The trial is a collaborative initiative bringing together expertise from the Institut National de Recherche Biomédicale in DRC, the Institute of Tropical Medicine in Belgium, and the University of Oxford in the UK. The WHO chief emphasized the importance of developing effective therapeutics, stating that while some individuals recover, many more lives could be saved with safe and effective treatment options.
